Company intelligence / Profile preview

Healthspan Capital

El Cerrito, California, United Stateshealthspancapital.vc ↗

Ownership: Private
Development stage: Other

Overview

Healthspan Capital does not develop drugs directly but invests in early-stage longevity biotech startups developing therapeutics to extend healthy human lifespan. Their portfolio covers pre-seed to Series A companies focused on rigorous science-backed approaches targeting aging and age-related diseases.

Therapeutic areas: Other
Modalities: Small moleculeBiologicGene therapyCell therapy
Industry: Investors

Partnerships

Collaborates with leading academic founders and institutions through investments but no formal pharma partnerships listed.

Beyond the preview

Go deeper on Healthspan Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healthspan Capital.

Explore the full profile